Genetron Holdings (Genetron Holdings) ROE % Adjusted to Book Value : -81.71% (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings ROE % Adjusted to Book Value?

Genetron Holdings's ROE % for the quarter that ended in Jun. 2022 was -94.78%. Genetron Holdings's PB Ratio for the quarter that ended in Jun. 2022 was 1.16. Genetron Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2022 was -81.71%.

Genetron Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Genetron Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings ROE % Adjusted to Book Value Chart

Genetron Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-3,721.94

-11.91

-66.15

Genetron Holdings Quarterly Data
	Dec17	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22
ROE % Adjusted to Book Value	Get a 7-Day Free Trial													-6.13	-17.34	-51.54	-81.71	-

Competitive Comparison of Genetron Holdings's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Genetron Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetron Holdings's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetron Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Genetron Holdings's ROE % Adjusted to Book Value falls into.

Genetron Holdings ROE % Adjusted to Book Value Calculation

Genetron Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-86.66%	/	1.31
	=	-66.15%

Genetron Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-94.78%	/	1.16
	=	-81.71%

Genetron Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetron Holdings (Genetron Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206

Website

https://www.genetronhealth.com

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.